Skip to main content
. 2020 Feb 10;43(4):1125–1132. doi: 10.3892/or.2020.7496

Figure 3.

Figure 3.

Piwil2-iCSC-Exo (200 µg/ml) enhance FB proliferation, migration and invasion. (A) The optimization experiments. (B) Proliferation of FBs after 0, 24, 48 and 72 h of incubation with Piwil2-iCSC-Exo. (C) Wound healing assays; representative images after 0, 12 and 24 h (×100 magnification). (D) Invasion assay; representative images (×100 magnification). At least 3 independent experiments were performed. Results were considered statistically significant at P<0.05 (**P<0.01, ***P<0.001 vs. control group; ##P<0.01, ###P<0.001 vs. PBS group). One-way ANOVA and the LSD post hoc test were selected for analysis. FBs, fibroblasts; Piwil2-iCSC-Exo, exosomes derived from Piwil2-induced cancer stem cells.